viimane versioon :
19/11/2024
Infostab
ingredientide nimekiri
nimekiri
Sobivus otsing
Y-liini sobivuse tabel
Viited
uurimisrühmad
valistab
plakat
Sidemed
sponsorid
Autor
Kasutusjuhend
ajakiri
Viited 472
tüüp :
ajaleht
uurimisrühmad :
Pierce - Lawn wood Regional Medical Center
Autor :
Wohlford JG, Fowler MD.
pealkiri :
Visual compatibility of hetastarch with injectable critical-care drugs.
publikatsioon :
Am J Hosp Pharm ; 46: 995-996. 1989
Tõendite tase :
füüsikaline stabiilsus :
Keemiline püsivus :
Muud meetodid :
Kommentaarid :
ingredientide nimekiri
Amikacin sulfate
5 mg/ml
+
Hetastarch
60 mg/ml
+
Ampicillin sodium
20 mg/ml
+
Hetastarch
60 mg/ml
+
Cefalotin sodium
20 mg/ml
+
Hetastarch
60 mg/ml
+
Cefamandole nafate
20 mg/ml
+
Hetastarch
60 mg/ml
+
Cefazolin sodium
20 mg/ml
+
Hetastarch
60 mg/ml
+
Cefonicid sodium
20 mg/ml
+
Hetastarch
60 mg/ml
+
Cefoperazone sodium
20 mg/ml
+
Hetastarch
60 mg/ml
+
Cefotaxime sodium
20 mg/ml
+
Hetastarch
60 mg/ml
+
Cefoxitin sodium
20 mg/ml
+
Hetastarch
60 mg/ml
+
Cimetidine hydrochloride
6 mg/ml
+
Hetastarch
60 mg/ml
+
Doxycycline hyclate
1 mg/ml
+
Hetastarch
60 mg/ml
+
Gentamicin sulfate
0.8 mg/ml
+
Hetastarch
60 mg/ml
+
Hetastarch
60 mg/ml
+
Amikacin sulfate
5 mg/ml
+
60 mg/ml
+
Ampicillin sodium
20 mg/ml
+
60 mg/ml
+
Cefalotin sodium
20 mg/ml
+
60 mg/ml
+
Cefamandole nafate
20 mg/ml
+
60 mg/ml
+
Cefazolin sodium
20 mg/ml
+
60 mg/ml
+
Cefonicid sodium
20 mg/ml
+
60 mg/ml
+
Cefoperazone sodium
20 mg/ml
+
60 mg/ml
+
Cefotaxime sodium
20 mg/ml
+
60 mg/ml
+
Cefoxitin sodium
20 mg/ml
+
60 mg/ml
+
Cimetidine hydrochloride
6 mg/ml
+
60 mg/ml
+
Doxycycline hyclate
1 mg/ml
+
60 mg/ml
+
Gentamicin sulfate
0.8 mg/ml
+
60 mg/ml
+
Ranitidine hydrochloride
0.5 mg/ml
+
60 mg/ml
+
Theophylline
4 mg/ml
+
60 mg/ml
+
Tobramycin sulfate
0.8 mg/ml
+
Ranitidine hydrochloride
0.5 mg/ml
+
Hetastarch
60 mg/ml
+
Theophylline
4 mg/ml
+
Hetastarch
60 mg/ml
+
Tobramycin sulfate
0.8 mg/ml
+
Hetastarch
60 mg/ml
+
Mentions Légales
